EDGIO INC (EGIO)

US53261M2035 - Common Stock

1.11  -0.27 (-19.57%)

After market: 1.0496 -0.06 (-5.44%)

Fundamental Rating

2

Overall EGIO gets a fundamental rating of 2 out of 10. We evaluated EGIO against 85 industry peers in the IT Services industry. EGIO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EGIO is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year EGIO has reported negative net income.
EGIO had a negative operating cash flow in the past year.
In the past 5 years EGIO reported 4 times negative net income.
Of the past 5 years EGIO 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of EGIO (-33.85%) is worse than 86.75% of its industry peers.
EGIO has a worse Return On Equity (-99.89%) than 74.70% of its industry peers.
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROIC N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 29.13%, EGIO is not doing good in the industry: 66.27% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EGIO has declined.
EGIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%

1

2. Health

2.1 Basic Checks

EGIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
EGIO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EGIO has more shares outstanding
The debt/assets ratio for EGIO has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.18, we must say that EGIO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EGIO (-2.18) is worse than 86.75% of its industry peers.
EGIO has a Debt/Equity ratio of 0.89. This is a neutral value indicating EGIO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.89, EGIO is not doing good in the industry: 63.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC3.38%

2.3 Liquidity

EGIO has a Current Ratio of 0.85. This is a bad value and indicates that EGIO is not financially healthy enough and could expect problems in meeting its short term obligations.
EGIO's Current ratio of 0.85 is on the low side compared to the rest of the industry. EGIO is outperformed by 79.52% of its industry peers.
A Quick Ratio of 0.85 indicates that EGIO may have some problems paying its short term obligations.
EGIO has a Quick ratio of 0.85. This is in the lower half of the industry: EGIO underperforms 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85

5

3. Growth

3.1 Past

EGIO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33866.67%.
Looking at the last year, EGIO shows a very strong growth in Revenue. The Revenue has grown by 37.59%.
Measured over the past years, EGIO shows a quite strong growth in Revenue. The Revenue has been growing by 12.93% on average per year.
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%

3.2 Future

EGIO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 118.32% yearly.
EGIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.99% yearly.
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

EGIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EGIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EGIO's earnings are expected to grow with 106.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-390.68%
EPS Next 3Y106.46%

0

5. Dividend

5.1 Amount

EGIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EDGIO INC

NASDAQ:EGIO (9/17/2024, 8:02:28 PM)

After market: 1.0496 -0.06 (-5.44%)

1.11

-0.27 (-19.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.50M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 29.13%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-4320%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y